维普期刊资源整合服务平台（V6.5）

68篇 您的检索式：作者名="VIGNETTI M"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	Interleukin-2 may induce prolonged remissons in advanced acute myelogenous leukemia显示文摘	Foa R Vignetti M	1994	Blood1994，84，：	1
2	Imatinib plus steroids induces complete remissions and prolonged survival in elderlyPhiladelphia chromosome-positive patient~ with acute lymphoblastic leukemia without additional chemotherapy: Results of the Gruppo haliano Malattie Enmtologiche dell' Adulto (GIMEMA) LAL0201-B protocol显示文摘	Vignetti M Fazi P Cimino G	2007	Blood2007，109，9：	1
3	Probability of long-term disease-free survival for acute myeloid leukemia patients after first relapse:a single-centre experience显示文摘	VIGNETTI M ORSINI E PETTI M C	1996	Ann Oncol1996，7，9：	1
4	Retinoic acid and arsenic trioxide for acute promyelocytic leukemia 显示文摘	Lo-CocoF Avvisati G Vignetti M	2013	N Engl J Med2013，369，2：	1
5	Daunorubicin versus mitoxantrone versus idarubicin as induction and consolidation chemotherapy for adults with acute myeloid leukemia:the EORTC and GIMEMA Groups Study AML-10显示文摘	Mandelli F Vignetti M Suciu S	2009	J Clin Oncol2009，27，32：	1
6	Front-line treatment of acute promyelocytic leukemia with AIDA induction followed by risk-adapted consolidation for adults younger than 61 years: results of the AIDA-2000 trial of the GIMEMA Group 显示文摘	Lo-Coco F Avvisati G Vignetti M	2010	Blood2010，116，17：	1
7	Front-line treatment of acute promyelocytic leukemia with AIDA induction followed by risk-adapted consolidation : results of the AIDA-2000 trial of the Italian GIMEMA Group显示文摘	Lo Coco F Avvisati G Vignetti M	2004	Blood2004，104，11：	1
8	Front-line treatment of acute promyelocytic leukemia with AIDA induction followed by risk-adapted consolidation for aduhsyounger than 61 years: results of the AIDA-2000 trial of the group显示文摘	Lo-Coco F Avvisati G Vignetti M	2010	Blood2010，116，17：	1
9	Retinoic acid and arsenic trioxide for acute promyelocytic leukemia显示文摘	Lo-Coco F Avvisati G Vignetti M	2013	New Engl J Med2013，369，2：	1
10	Retinoic acid and arsenic trioxide for acute promyelocytic leukemia显示文摘	Lo-Coco F Avvisati G Vignetti M	2013	N Engl J Med2013，369，2：	1
11	Front-line treat- ment of acute promyelocytic leukemia with AIDA induc-tion followed by risk-adapted consolidation for adults younger than 61 years显示文摘	Lo-Coco F Avvisati G Vignetti M	2010	Blood2010，116，17：	1
12	Extramedullary involvement at relapse in acute Incidence of extramedullary disease in acute promyelocytic leukemia patients treated or not with all- trans retinoic acid: a report by the Gruppo Italiano Malattie Ematologiche dell' Adulto 显示文摘	Specchia G Lo Coco F Vignetti M	2001	J Clin Oncol2001，19，20：	1
13	Front-line treatment of acute promyeloeytic leukemia with AIDA induction followed by risk-adapted consolidation for adults younger than 61 years: results of the AIDA-2000 trial of the GIMEMA Group 显示文摘	Lo-Coco F Avvisati G Vignetti M	2010	Blood2010，116，17：	1
14	Daunorubicin versus mitoxantrone versus idarubicin as induction and consolidation chemotherapy for adults with acute myeloid leukemia: The EORTC and GIMEMA Groups Study AML-10显示文摘	Mandelli F Vignetti M Suciu S	2009	J Clin Oneol2009，27，32：	1
15	Retinoic acid and arsenic trioxide for acute promyelocytic leukemia显示文摘	Lo-Coco F Avvisati G Vignetti M	2013	N Engl J Med2013，369，2：	1
16	Retinoic acid and arsenic trioxide for acute promyelocytic leukemia显示文摘	Lo-Coco F Avvisati G Vignetti M	2013	N Engl J Med2013，369，2：	1
17	Daunorubicin versus mitoxantrone versus idarubicin as induction and consolidation chemotherapy for adults with acute myeloid leukemia: the EORTC and GIMEMA Groups Study AML-10 显示文摘	Mandelli F Vignetti M Suciu S	2009	J Clin Oncol2009，27，32：	1
18	Retinoic acid and arsenic trioxide for acute promyelocytic leukemia显示文摘	Lo-Coco F Avvisati G Vignetti M	2013	N Engl J Med2013，369，2：	1
19	Front-line treatment of acute promyelocytic leukemia with AIDA induction followed by risk-adapted consolidation: resuits of the AIDA- 2000 trial of the Italian GIMEMA group显示文摘	Lo-Coco F Avvisati G Vignetti M	2004	Blood2004，104，17：	1
20	Front-line treatment of acute promyelocytic leukemia with AIDA induction followed by risk-adapted con- solidation for adults younger than 61 years:results of the AIDA- 2000 trial of the GIMEMA Group 显示文摘	Lo-Coco F Avvisati G Vignetti M	2010	Blood2010，116，17：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示